There were 1,914 press releases posted in the last 24 hours and 358,969 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image